Globus Medical, Inc.
GMED
$76.64
-$0.57-0.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.04% | 25.73% | 22.91% | 18.37% | -1.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.04% | 25.73% | 22.91% | 18.37% | -1.41% |
| Cost of Revenue | 19.82% | 17.82% | -9.00% | -6.64% | 4.09% |
| Gross Profit | 30.54% | 29.61% | 47.21% | 35.96% | -3.87% |
| SG&A Expenses | 22.67% | 20.58% | 18.50% | 26.76% | -1.12% |
| Depreciation & Amortization | 2.51% | -1.85% | -0.77% | 1.62% | -2.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.61% | 17.44% | 4.01% | 8.71% | -3.62% |
| Operating Income | 64.84% | 60.99% | 238.07% | 105.47% | 11.60% |
| Income Before Tax | 51.52% | 586.07% | 152.48% | 295.48% | 1,311.36% |
| Income Tax Expenses | 16.19% | 1,658.16% | 381.68% | -192.74% | 2,057.39% |
| Earnings from Continuing Operations | 64.72% | 430.44% | 129.50% | 538.68% | 1,160.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.72% | 430.44% | 129.50% | 538.68% | 1,160.31% |
| EBIT | 64.84% | 60.99% | 238.07% | 105.47% | 11.60% |
| EBITDA | 41.44% | 40.64% | 105.68% | 57.78% | 14.32% |
| EPS Basic | 66.42% | 439.45% | 131.42% | 538.70% | 1,149.05% |
| Normalized Basic EPS | 61.33% | 125.20% | 194.49% | 114.83% | 45.22% |
| EPS Diluted | 66.67% | 436.89% | 131.58% | 547.83% | 1,126.62% |
| Normalized Diluted EPS | 61.51% | 126.50% | 197.77% | 115.60% | 42.10% |
| Average Basic Shares Outstanding | -1.02% | -1.70% | -0.82% | 0.01% | 1.03% |
| Average Diluted Shares Outstanding | -1.13% | -2.25% | -1.93% | -0.35% | 3.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |